The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer

Author:

Turvill James L,Turnock Daniel,Cottingham Dan,Haritakis Monica,Jeffery Laura,Girdwood Annabelle,Hearfield Tom,Mitchell Alex,Keding Ada

Abstract

BackgroundThe faecal immunochemical test (FIT) is now available to support clinicians in the assessment of patients at low risk of colorectal cancer (CRC) and within the bowel cancer screening programme.AimTo determine the diagnostic accuracy of FIT for CRC and clinically significant disease in patients referred as they were judged by their GP to fulfil National Institute for Health and Care Excellence guideline 12 (NG12) criteria for suspected CRC.Design and settingPatients referred from primary care with suspected CRC, meeting NG12 criteria, to 12 secondary care providers in Yorkshire and Humber were asked to complete a FIT before investigation.MethodThe diagnostic accuracy of FIT based on final diagnosis was evaluated using receiver operating characteristics analysis. This permitted a statistically optimal cut-off value for FIT to be determined based on the maximisation of sensitivity and specificity. Clinicians and patients were blinded to the FIT results.ResultsIn total, 5040 patients were fully evaluated and CRC was detected in 151 (3.0%). An optimal cut-off value of 19 µg Hb/g faeces for CRC was determined, giving a sensitivity of 85.4% (95% confidence interval [CI] = 78.8% to 90.6%) and specificity of 85.2% (95% CI = 84.1% to 86.2%). The negative predictive value at this cut-off value was 99.5% (95% CI = 99.2% to 99.7%) and the positive predictive value 15.1% (95% CI = 12.8% to 17.7%). Sensitivity and specificity of FIT for CRC and significant premalignant polyps at this cut-off value were 62.9% (95% CI = 57.5% to 68.0%) and 86.4% (95% CI = 85.4% to 87.4%), respectively; and when including all organic enteric disease were 35.7% (95% CI = 32.9% to 38.5%) and 88.6% (95% CI = 87.5% to 89.6%), respectively.ConclusionFIT used in patients fulfilling NG12 criteria should allow for a more personalised CRC risk assessment. FIT should permit effective, patient-centred decision-making to inform the need for, type, and timing of further investigation.

Publisher

Royal College of General Practitioners

Subject

Family Practice

Reference56 articles.

1. National Institute for Health and Care Excellence (2021) Suspected cancer: recognition and referral, NG12, https://www.nice.org.uk/guidance/ng12 (accessed 5 Jul 2021).

2. Department of Health (2000) The NHS cancer plan, https://www.thh.nhs.uk/documents/_Departments/Cancer/NHSCancerPlan.pdf (accessed 5 Jul 2021).

3. NHS England (2021) Monthly diagnostics data 2019–20. https://www.england.nhs.uk/statistics/statistical-work-areas/diagnostics-waiting-times-andactivity/monthly-diagnostics-waiting-times-and-activity/monthly-diagnosticsdata-2019-20 (accessed 5 Jul 2021).

4. NHS England (2021) Monthly diagnostics data 2020–21. https://www.england.nhs.uk/statistics/statistical-work-areas/diagnostics-waiting-times-andactivity/monthly-diagnostics-waiting-times-and-activity/monthly-diagnosticsdata-2020-21 (accessed 5 Jul 2021).

5. NHS England (2021) Monthly provider based data and summaries. https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/monthly-prov-cwt (accessed 5 Jul 2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3